SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $117,183 | +72.9% | 98,061 | 0.0% | 0.07% | +61.9% |
| Q1 2023 | $67,780 | +1.8% | 98,061 | 0.0% | 0.04% | -2.3% |
| Q4 2022 | $66,583 | -35.4% | 98,061 | -1.8% | 0.04% | -41.9% |
| Q3 2022 | $103,000 | +51.5% | 99,819 | 0.0% | 0.07% | +64.4% |
| Q2 2022 | $68,000 | -19.0% | 99,819 | 0.0% | 0.04% | 0.0% |
| Q1 2022 | $84,000 | -52.5% | 99,819 | -7.8% | 0.04% | -48.3% |
| Q4 2021 | $177,000 | -32.2% | 108,286 | 0.0% | 0.09% | -34.1% |
| Q3 2021 | $261,000 | -8.4% | 108,286 | +0.3% | 0.13% | -9.6% |
| Q2 2021 | $285,000 | -73.9% | 107,960 | -50.7% | 0.15% | -53.5% |
| Q1 2021 | $1,092,000 | +360.8% | 218,920 | +45.9% | 0.31% | +129.2% |
| Q4 2020 | $237,000 | +68.1% | 150,000 | 0.0% | 0.14% | +29.2% |
| Q3 2020 | $141,000 | -7.2% | 150,000 | 0.0% | 0.11% | -18.5% |
| Q2 2020 | $152,000 | +105.4% | 150,000 | 0.0% | 0.13% | +46.1% |
| Q1 2020 | $74,000 | – | 150,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENDELL JEFFREY L | 4,933,024 | $4,133,000 | 0.30% |
| ACUTA CAPITAL PARTNERS, LLC | 295,896 | $248,000 | 0.12% |
| Connacht Asset Management LP | 231,551 | $194,000 | 0.10% |
| Uniplan Investment Counsel, Inc. | 1,564,605 | $1,310,000 | 0.08% |
| AdvisorShares Investments LLC | 358,796 | $301,000 | 0.05% |
| 1492 Capital Management LLC | 99,819 | $84,000 | 0.04% |
| Woodline Partners LP | 2,803,230 | $2,349,000 | 0.04% |
| Ikarian Capital, LLC | 257,883 | $215,000 | 0.03% |
| Sovereign Financial Group, Inc. | 75,000 | $63,000 | 0.02% |
| Aquatic Capital Management LLC | 6,400 | $5,000 | 0.01% |